Citizens Business Bank Grows Stock Holdings in Colgate-Palmolive Company $CL

Citizens Business Bank increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 97.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,912 shares of the company’s stock after purchasing an additional 28,615 shares during the period. Citizens Business Bank’s holdings in Colgate-Palmolive were worth $4,629,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Brighton Jones LLC increased its holdings in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares during the last quarter. Woodline Partners LP lifted its stake in Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after buying an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. boosted its stake in Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after purchasing an additional 245 shares during the period. Resonant Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth about $233,000. Finally, Envestnet Asset Management Inc. grew its stake in shares of Colgate-Palmolive by 0.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock valued at $61,662,000 after purchasing an additional 2,768 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. This represents a 77.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.34% of the company’s stock.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Investor visibility: Colgate will webcast a fireside chat at the UBS Global Consumer & Retail Conference (March 11). Management access and the Q&A may provide clarity on growth plans and could support the stock if management delivers reassuring execution or guidance. Colgate-Palmolive Webcasts Fireside Chat at the UBS Global Consumer and Retail Conference 2026
• Positive Sentiment: Momentum/technical improvement: Coverage notes that CL is up strongly year-to-date and recently received a Relative Strength rating upgrade, which can attract momentum investors and support the share price. Colgate-Palmolive Stock Up 23% So Far This Year, Shines Brightly. Gets Rating Upgrade.
• Neutral Sentiment: Peer/comparative coverage: Multiple write-ups compare CL versus peers like Procter & Gamble on growth, margins and valuation — useful context for investors sizing relative upside but not an immediate catalyst. Procter & Gamble vs. Colgate: Which Consumer Stock Has More Upside?
• Neutral Sentiment: Industry backdrop: A new market report highlights long-term growth in beauty/personal-care markets and lists Colgate among major players — a positive structural tailwind but not an immediate stock mover. Global Cosmetics Market Competitive Landscape Report 2025
• Negative Sentiment: Execution risk flagged: Analysts note newly disclosed execution risks tied to Colgate’s three-year strategic growth and productivity program — risks to delivery could pressure sentiment if targets slip. Execution Risks Loom Over Colgate-Palmolive’s 3-Year Strategic Growth and Productivity Program
• Negative Sentiment: Governance/debate over DEI: Colgate is publicly defending DEI criteria for board selection against a shareholder proposal, which creates proxy-season noise and potential reputational or governance risk. Colgate-Palmolive plans to defend DEI criteria for board selection, letter shows
• Negative Sentiment: Options activity: Unusual put buying (notably higher-than-average volume) suggests some investors are hedging or betting on downside, which can amplify near-term selling pressure.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on CL shares. UBS Group lifted their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday, January 14th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Wells Fargo & Company increased their price target on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a report on Monday, February 2nd. Finally, Morgan Stanley increased their target price on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $96.63 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.27 and a debt-to-equity ratio of 18.82. The company’s 50-day moving average price is $86.68 and its 200 day moving average price is $82.53. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The stock has a market cap of $77.89 billion, a price-to-earnings ratio of 36.88, a PEG ratio of 4.43 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share. As a group, research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.